2. April 2006. Mr C, 35 year-old, executive
No significant medical history
Hystory of the disease :
– progressive tiredness during last 6 months
– Dry cough during 3 days
– Paroxysmal nocturnal dyspnoea :
• Dyspnoea/orthopnoea/sensation of imminent death
Ambulance:
– BP : 140/90 ; HR : 120 ; Oxygen saturation : 75 %
3. AAccuuttee mmaannaaggeemmeenntt
Emergency room:
• Non-invasive ventilation with O2
• ECG : sinusal rhythm 120 bpm ; no sign of myocardial infarction
• IV line:
- Lasilix : 80 mg IVD
- TNT : 1 follow by 2 mg/h
4. AAfftteerr ssttaabbiilliizzaattiioonn
Intensive care unit : D1-D2
O2 : 3 liters/min during 24 h
Lasilix : 40 mg x 4 IVD only during first 24 h
Per-os :
- Coversyl 5 mg/day
- Kardegic 75 mg : 1/day
- Lasilix 80 mg per-os D2 and D3 follow by 40 mg/day
- Aldactone : 25 mg/d
7. Corelation between BBNNPP lleevveellss //NNYYHHAA ccllaassss
BNP (pg/mL)
1200
1000
800
600
400
200
0
Normal Class I Class II Class III Class IV
12.3 95.4 221.5 459.1
1006.3
17. IIddiiooppaatthhiicc DDMMCC
Family history: the patient had an uncle who died from HF at 50
years
MRI does not show any specific etiology
18. HHoolltteerr
Sustained Sinus rythm: 80 bpm
No bradycardia, no pause
Rare PVC :
• 300 in 24 h and 5 bigeminy
19. DDeetteeccttiioonn ooff sslleeeepp aappnnooeeaa
SAS quite severe
• AHI = 35/hour (every episode > 10 sec)
• Central (typically for HF)
Indication for device by bi-pap
20.
21. VO 2 Exercise tteesstt ((DD1133)) :: aa vveerryy ppoooorr
ppeerrffoorrmmaannccee
Exercise test: bicycle protocol 10w/min
• Performed up to 120 watts
• Exercise duration : 6 min 40 sec
• HR: at rest : 85 bpm, max : 131 bpm
• SBP : at rest : 85 mmHg, max : 100 mmHg
Peak VO2 = 12 ml/kg/mn
22. AAnndd tthheenn……
Rehabilitation program in CRC (D7-D 20)
Medical treatment :
• Lasilix 40, Aldactone 25, Coversyl 7,5
• Bisoprolol 3,75 mg, Procoralan 10 mg
bi-pap device (D40)
Go back to work part-time on D30
24. Re-evaluation at D60: a ppaattiieenntt ssttaabbllee aanndd wweellll
ttrreeaatteedd
Echography : no change, no complication
• LV dilatation , hypokinetic (LVEF : 25 %) ; no thrombus
Mitral insufficiency grade 1
• No H-sPAP
Blood tests:
• BNP = 350 ; normal renal fuction
Exercise test
• Performed up to 150 watts
• Peak VO2 : 14,2 ml/kg/min
Clinical evaluation :
• Pauci-symptomatic (NYHA = 2)
• SBP : 90 mmHg ; HR : 69 bpm
25. CCoonncclluussiioonn
Pharmacological treatment :no need to change
• Lasilix 40, aldactone 25, coversyl 10, cardensiel 5, procoralan 15
Recommendation for defibrillator
• LVEF < 35 %
No indication for transplantation
Close monitoring: 3 times / year by the physician and 1time /y in
Ambulatory center at University Hospital
28. EEvvoolluuttiioonn ((11))
Normal activity
Nothing new during 18 months
Hospitalisation 10 days for APO on the 28th of December, 2007
• due to bronchitis (infection) and Christmas diner ( salty food)
Therapeutical education ++
Rehabilitation (exercise training) ++
29. EEvvoolluuttiioonn ((22))
Nothing new from January to August 2008
During holidays :
• Fatigue, dyspnoea (NYHA class 3), weight gain (4 kg in 1
month)
Check after holidays :
- ECG : sinus rhythm, reveals a Left Bundle Branch Block : sign
of myocardial deterioration
- Echo : LVEF : 20 %, hypokinesia of LV and RV
- SBP : 90 mmHg, HR : 65 bpm, BNP : 890
Reinforce the medical treatment (diuretics)
Indication for Pacemaker: Cardiac resynchronization therapy
15 /09/2008
33. EEvvoolluuttiioonn ((11))
Moderate improvement in symptoms
• NYHA Class 2-3 ; dyspnoea at 2 levels
• No inferior limbs oedema
Go back to work on D30 (15 octobre 2008)
• Stops again on 01/11/08 for tiredness
34. EEvvoolluuttiioonn ((22))
Nov 2008- sept 2009 : he is slowly going downhill
• Dyspnoea at only one floor (37 years old)
• 2 moderate acute HF episodes with no need for hospitalisation but
requirement for treatment modifications:
- Cardensiel 3.75, Procoralan 15, Coversyl 10, Aldactone 50,
Lasilix 160, Hémigoxine: 1 cp
Mental depression ,Fatigue, anorexia, loss of weight (muscle atrophy)
But you can see that their prognosis was very different
Indeed 31 percent of non responive patients presented an adverse event while only 4% percent of the responive ones presented a cardiac event during the 2 years follow-up